DENVER--(BUSINESS WIRE)--Posterity Health, the only digital male fertility center of excellence that offers personalized advice, educational resources, and effective male fertility treatments, today announced an oversubscribed funding round of $7.5M led by early-stage venture capital fund Distributed Ventures. The funding reinforces the importance of evaluating the male partner when a couple is having trouble conceiving. The new capital will accelerate the company’s Digital Health Platform and provide access to male fertility testing and treatment on a national scale. This expansion has been crisply synchronized to capitalize on the new male fertility benefits that became effective on January 1, 2023.
“This funding allows us to move one step closer to achieving our mission to provide access to male fertility care for every couple trying to conceive,” said Pam Pure, CEO of Posterity Health. “Male fertility specialists are scarce resources with approximately 200 fellowship trained physicians in the country. In addition, males prefer evaluation and treatment from home. The expanded Posterity Health network will double the number of reproductive urologists using the platform and provide easy access to in-person care when required.”
Early data culled from Posterity Health’s hormone management study of its patients demonstrates the importance and power of proactive treatment as well as validation of Posterity Health’s care model. For instance, data revealed that nearly 70 percent of males receiving hormone management therapy had an improved sperm count.
"There is an increasing demand for the services and expertise that are unique to Posterity Health, making Distributed Ventures’ funding a crucial component of our goal to provide support for nascent healthtech companies. We’re proud to support Posterity Health’s mission to make male fertility care more accessible while ending the stigma surrounding it at an imperative time when these services are in high demand,” said Shawn Ellis, Managing Partner at Distributed Ventures. “By leading an investment in Posterity Health, we are investing in the digital transformation technologies that are crucial for increasing access to innovative and comprehensive healthcare.”
Posterity Health is pleased to welcome FCA Venture Partners and WVV Capital to the round, both of which are experienced digital healthcare investors with the expertise to extend Posterity Health’s position as the leader in Male Fertility Care.
“It’s been a pivotal next step for fertility benefits coverage to cover the costs of male care and encourage the male evaluation. Posterity Health’s distinctive model makes it possible for couples across the country to have access to Reproductive Urologists who have been specialty trained to identify and treat male fertility,” said Tom Hearn, Partner, FCA Venture Partners. “The integrated care, as well as OBGYN support that Posterity Health provides, furthers the early and simultaneous evaluation of both partners when a couple is having trouble conceiving. The Posterity Health offering will help each couple find their best path to pregnancy.”
Posterity Health provides a comprehensive range of male fertility services and delivers the Posterity Health care protocols that have been developed conjunction with the Medical Advisory Board, which consists of the top male fertility leaders in the country, including Dr. Peter Schlegel, James J Colt Professor of Urology at Weill Cornell Medicine, Dr. James Smith, the Director of the Male Reproductive Health Center at UCSF and Dr. Stan Honig, the Director of Men’s Health at Yale University.
The company’s Digital Health Platform includes virtual visits, at-home diagnostics, and in-person consultations to help assess and improve the male patients' fertility status. Services include baseline assessments, sperm preservation, semen analysis, pregnancy loss consults, diagnostic workups, vasectomy reversals and gender affirming care.
About Posterity Health
Posterity Health provides an extensive portfolio of technology-enabled male fertility services, including at-home diagnostics, virtual visits and in-person consults focused on improving a man’s fertility status. The company seeks to educate, engage, and treat men, shifting the burden of conceiving from solely the woman and creating a unifying experience for the couple.
Posterity Health is committed to making male fertility management a core part of men’s health. To learn more, visit www.posterityhealth.com.
About Distributed Ventures
Distributed Ventures is a Seed to Series B focused fund that invests in entrepreneurs as they transform the future of risk across Fintech, Insurtech, and Digital Health and Benefits. As former founders, investors, and operators, the Distributed Ventures team provides deep subject matter and early-stage operational expertise to help companies find success from day one. Distributed Ventures was born out of NFP Ventures with the goal of helping entrepreneurs demonstrate product-market fit and accelerate commercial traction via diverse distribution channels. For more information, visit distributedvc.com.
About FCA Venture Partners
FCA Venture Partners is a venture capital firm investing in early-stage healthcare technology and technology-enabled healthcare services companies that improve patient care, reduce costs, and increase efficiency. FCA manages over $100M and invests across the Series Seed to Series B stages. FCA brings portfolio companies valuable healthcare insights, connections, and board-level experience to accelerate growth and build disruptive and sustainable businesses. Based in Nashville, the epicenter of healthcare innovation, with a strategic network in Charlotte and Winston-Salem, NC, the FCA team has a decades-long track record including more than 60 investments in the rapidly changing healthcare industry.
